موضوع: tesofensine regulatory approval

As a whole, the safety profile of tesofensine is similar to presently authorized medicines for the therapy of obesity. The most typically reported negative effects in the overweight populace were completely dry mouth, headache, nausea or vomiting, insomnia, looseness of the bowels and bowel irregularity. New study is exposing the surprising mind and mental wellness advantages of semaglutide medicines such as Ozempic and Wegovy, and various other related diabetic issues and weight-loss drugs t...